Tofacitinib for Immune Skin Conditions in Down Syndrome

Clinical trial NCT04246372 · COMPLETED

Trial details

NCT number: NCT04246372
Sponsor: University of Colorado, Denver
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Down Syndrome Alopecia Areata Atopic Dermatitis / Eczema Hidradenitis Suppurativa Vitiligo Psoriasis

Start date: 2020-10-21
Primary completion: 2024-10-30
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.